HCM
ABPI

Highlander Capital Management’s Accentia Biopharmaceuticals ABPI Stock Holding History

Highlander Capital Management’s Portfolio ABPI Stock Details ABPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,874
Closed – – 886
2015
Q2 		$0 Buy
+16,874
New – ﹤0.01% 887
2015
Q1 		– Sell
-16,874
Closed – – 877
2014
Q4 		$0 Hold
16,874
– – ﹤0.01% 889
2014
Q3 		$25 Hold
16,874
– – ﹤0.01% 857
2014
Q2 		$66 Hold
16,874
– – ﹤0.01% 815
2014
Q1 		$135 Hold
16,874
– – ﹤0.01% 831
2013
Q4 		$47 Hold
16,874
– – ﹤0.01% 831
2013
Q3 		$84 Hold
16,874
– – ﹤0.01% 830
2013
Q2 		$197 Buy
+16,874
New +$197 ﹤0.01% 808

Highlander Capital Management's ABPI Position: Q3 2015 in Review

Highlander Capital Management sold out of Accentia Biopharmaceuticals (ABPI) in Q3 2015, closing a stake of 16,874 shares.

Highlander Capital Management first reported a position in ABPI in Q2 2013 and held it in 8 quarters. The position peaked at $197 in Q2 2013. 1 fund tracked by Wall St. Rank holds ABPI as of Q3 2015.

  • Highlander Capital Management reported no remaining Accentia Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Highlander Capital Management sold 16,874 Accentia Biopharmaceuticals shares in Q3 2015.
  • Highlander Capital Management first reported a position in Accentia Biopharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Highlander Capital Management's Accentia Biopharmaceuticals position peaked at $197 in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Accentia Biopharmaceuticals as of Q3 2015.

Based on Highlander Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.